Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03623243
Brief Title: Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients. (EXCHANGE)

First Submitted : August 7, 2018
First Submitted that Met QC Criteria : August 8, 2018
First Posted : August 9, 2018

Last Update Submitted that Met QC Criteria : August 10, 2021
Last Update Posted : August 11, 2021